Skip to main content
Clinical Trials/NCT05723861
NCT05723861
Completed
Not Applicable

Virtual Reality During Colonoscopy

Herlev and Gentofte Hospital1 site in 1 country50 target enrollmentMarch 22, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Virtual Reality
Sponsor
Herlev and Gentofte Hospital
Enrollment
50
Locations
1
Primary Endpoint
Patient pain before colonoscopy procedure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This project will use a randomized controlled trial to test the effect of using Virtual Reality on pain, anxiety, patients' comfort, and satisfaction during colonoscopy. Patients will use a virtual reality head-mounted display and choose a visualized VR content to watch during colonoscopy. Colonoscopy will be initiated without standard sedatives and narcotics and using virtual reality distraction for as long as the patient would like (for a maximum of 20 minutes). Participants could opt out and/or request standard medications for pain at any time before or during the procedure.

Detailed Description

This project aims to investigate the clinical effectiveness and implementation potential of using VR during colonoscopy using a hybrid type 1 effectiveness-implementation design through 2 work packages. The first work package will investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy using a multicenter parallel randomized controlled, open-label trial. It will also be a qualitative interview to explore the healthcare professionals' and patients' experiences with using VR during colonoscopy. The second work package will evaluate the implementation process using mix method to understand why the intervention is (or is not) more effective than usual care, whether high intervention fidelity is achieved, what barriers and facilitators there are, how these may translate into real-world implementation, and what modifications can be made to maximize implementation success. This will be achieved using quantitative and qualitative approaches with a focus on the process evaluation around the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance). Quantitative (e.g., quantitative analysis of patient participation rate and reasons for refusal assessment or ineligibility) and qualitative (e.g., qualitative interview of facilitators/barriers to implementing VR) data analyses will be combined to conclude the reach, adoption, implementation, and maintenance of the intervention. The specific aims of the project will be pursued through 2 work packages and include: Intervention effectiveness work package Study I: To investigate the effect of VR on pain, anxiety, patients' comfort, and satisfaction during colonoscopy. Study II: To explore the healthcare professionals' and patients' experiences with using VR during colonoscopy. Implementation work package Qualitative part: 1. To explore facilitators/barriers to adoption and implementing using VR during colonoscopy. 2. To explore the facilitators/barriers to sustaining using VR during colonoscopy after the study was completed. Quantitative part: 1) To examine the potential of using VR under colonoscopy for reach and adoption. Participants will be recruited from adult patients referred to the two outpatient Endoscopy Units. Patients who meet the inclusion criteria and give written consent will be consecutively enrolled in the trial. These patients will be randomly allocated to an experimental group (using VR), or a control group (routine care). Outcomes will be measured immediately before, after, and/or during the procedure. Some patients in the intervention group and healthcare professionals will be asked to participate in a qualitative interview to share their experiences of using VR under colonoscopy and to evaluate the implementation process.

Registry
clinicaltrials.gov
Start Date
March 22, 2023
End Date
June 28, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mahdi Shamali

Postdoc Researcher

Herlev and Gentofte Hospital

Eligibility Criteria

Inclusion Criteria

  • any elective indication of colonoscopy

Exclusion Criteria

  • having visual impairments,
  • having dementia
  • limited Danish language skills
  • a high tendency to travel sickness
  • having skin disease in the facial area
  • having epilepsy

Outcomes

Primary Outcomes

Patient pain before colonoscopy procedure

Time Frame: 5 - 15 minutes before starting colonoscopy.

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient anxiety after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

Patient comfort after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

Patient anxiety before colonoscopy procedure

Time Frame: 5 - 15 minutes before starting colonoscopy.

Patient anxiety will be measured by the short form of the State Trait Anxiety Inventory (STAI) which has five items with a 4-point Likert-type scale ranging from 0 to 3.

Patient pain during colonoscopy procedure

Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient pain after colonoscopy procedure

Time Frame: 5 - 15 minutes after the colonoscopy is ended.

Patients will rate their pain using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 10 (highest imaginable pain).

Patient comfort during colonoscopy procedure

Time Frame: During the colonoscopy procedure (from the time colonoscopy is started until ended).

Patient comfort will be measured by a nurse/researcher using the five-point Modified. Gloucester Comfort Scale (MGCS) ranging from 1 (no discomfort) to 5 (severe discomfort).

Secondary Outcomes

  • Patient / healthcare professional experience with using VR during colonoscopy(30 minutes - one week after the procedure)
  • Patient satisfaction(5 - 15 minutes after the colonoscopy is ended.)

Study Sites (1)

Loading locations...

Similar Trials